Skip to main content
Premium Trial:

Request an Annual Quote

Isogenica Gets $909,249 from EU to Screen Peptides Libraries

NEW YORK (GenomeWeb News) – Isogenica today said it has received a three-year, €700,000 ($909,249) grant as part of a project to develop a system for the "deep" screening of peptide libraries against therapeutic targets.

The funding to Isogenica is through the European Commission's Seventh Framework Programme and is part of a €5.5 million project with consortium grant funding of about €4 million. The grant began in January.

Isogenica will combine its CIS display techniques with high-throughput sequencing to screen hundreds of trillions of peptides and to identify up to 100,000 peptide hits against target proteins, the Cambridge, UK-based firm said.

Other members of the project include Apogenix; Biametrics; the Center for Advanced Bioanalysis; the German Cancer Research Centre; the Karlsruher Institute for Technology; Microsystems; PepPerPrint; the Technical University of Varna; and the MRC Weatherall Institute of Molecular Medicine at the University of Oxford.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.